AFT Pharmaceuticals Limited (AFT.NZ)
NZD 2.62
(0.0%)
NZD 2.62
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 195.41 Million | 155.82 Million | 129.83 Million | 112.86 Million | 105.24 Million | 84.87 Million |
| Cost of Revenue | 107.13 Million | 83.65 Million | 68.53 Million | 64.36 Million | 57.33 Million | 44.39 Million |
| Gross Profit | 88.27 Million | 72.16 Million | 61.29 Million | 48.49 Million | 47.9 Million | 40.47 Million |
| Operating Expenses | 64.03 Million | 55.03 Million | 41.61 Million | 39.76 Million | 38.07 Million | 36.64 Million |
| Selling, General and Administrative Expenses | 56.47 Million | 47.66 Million | 36.1 Million | 35.22 Million | 35.31 Million | 33.74 Million |
| Research and Development Expenses | 8.09 Million | 5.64 Million | 5.5 Million | 3.43 Million | 1.98 Million | 2.58 Million |
| Other Expenses | - | -189 Thousand | 1.43 Million | 1.48 Million | 10.67 Million | 2.49 Million |
| Cost and Expenses | 171.17 Million | 138.69 Million | 110.15 Million | 104.12 Million | 95.41 Million | 81.04 Million |
| Operating Income | 24.23 Million | 18.67 Million | 20.07 Million | 11.32 Million | 20.92 Million | 6.15 Million |
| Interest Expense | 3.68 Million | 2.87 Million | 2.43 Million | 3.44 Million | 8.05 Million | 8.41 Million |
| Income Tax Expense | 6.41 Million | 5.14 Million | -1.16 Million | 105 Thousand | 185 Thousand | 168 Thousand |
| Earnings before Tax | 22.01 Million | 15.79 Million | 18.68 Million | 7.88 Million | 12.87 Million | -2.25 Million |
| Net Income | 15.6 Million | 10.65 Million | 19.84 Million | 7.78 Million | 12.69 Million | -2.42 Million |
| Earnings Per Share Basic | 0.15 | 0.10 | 0.19 | 0.07 | 0.12 | -0.02 |
| Earnings Per Share Diluted | 0.15 | 0.10 | 0.19 | 0.07 | 0.12 | -0.02 |
| Weighted Average Shares Outstanding | 104.86 Million | 104.84 Million | 104.68 Million | 103.29 Million | 97.3 Million | 97.3 Million |
| Weighted Average Shares Outstanding (Diluted) | 104.86 Million | 104.84 Million | 104.68 Million | 103.29 Million | 97.3 Million | 97.3 Million |
| Gross Margin | 0.45 | 0.46 | 0.47 | 0.43 | 0.46 | 0.48 |
| EBIT Margin | 0.13 | 0.13 | 0.16 | 0.11 | 0.21 | 0.08 |
| Profit Margin | 0.08 | 0.07 | 0.15 | 0.07 | 0.12 | -0.03 |
| EBITDA | 25.72 Million | 20.39 Million | 21.12 Million | 12.43 Million | 21.03 Million | 3.95 Million |
| Earnings Before Tax Margin | 0.12 | 0.12 | 0.15 | 0.10 | 0.20 | 0.07 |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 55.89 Million | 195.41 Million | 55.89 Million | 83.61 Million | 41.8 Million | 90.89 Million |
| Cost of Revenue | 29.73 Million | 107.13 Million | 29.73 Million | 47.67 Million | 23.83 Million | 46.58 Million |
| Gross Profit | 26.16 Million | 88.27 Million | 26.16 Million | 35.93 Million | 17.96 Million | 44.3 Million |
| Operating Expenses | 15.67 Million | 64.56 Million | 15.22 Million | 32.77 Million | 16.09 Million | 28.09 Million |
| Selling, General and Administrative Expenses | 14.41 Million | - | 14.41 Million | 29.26 Million | 14.63 Million | 25.22 Million |
| Research and Development Expenses | 2.66 Million | - | 2.66 Million | 3.5 Million | 1.75 Million | 2.86 Million |
| Other Expenses | -1.4 Million | 3.3 Million | - | - | - | - |
| Cost and Expenses | 45.4 Million | 171.7 Million | 44.95 Million | 80.44 Million | 39.93 Million | 74.67 Million |
| Operating Income | 10.49 Million | 23.7 Million | 10.49 Million | 3.16 Million | 1.62 Million | 16.21 Million |
| Interest Expense | 1.87 Million | 3.68 Million | - | 1.81 Million | - | 1.47 Million |
| Income Tax Expense | 3.12 Million | 6.41 Million | 3.12 Million | 152 Thousand | 76 Thousand | 4.47 Million |
| Earnings before Tax | 10.02 Million | 22.01 Million | 10.02 Million | 1.96 Million | 984 Thousand | 13.67 Million |
| Net Income | 6.89 Million | 15.6 Million | 6.89 Million | 1.81 Million | 908 Thousand | 9.2 Million |
| Earnings Per Share Basic | 0.06 | - | 0.06 | 0.02 | 0.01 | 0.09 |
| Earnings Per Share Diluted | 0.06 | - | 0.06 | 0.02 | 0.01 | 0.09 |
| Weighted Average Shares Outstanding | 118.93 Million | 104.86 Million | 118.93 Million | 104.86 Million | 90.8 Million | 104.86 Million |
| Weighted Average Shares Outstanding (Diluted) | 118.93 Million | 104.86 Million | 118.93 Million | 104.86 Million | 90.8 Million | 104.86 Million |
| Gross Margin | 0.47 | 0.45 | 0.47 | 0.43 | 0.43 | 0.49 |
| EBIT Margin | 0.20 | - | 0.20 | 0.05 | 0.04 | 0.19 |
| Profit Margin | 0.12 | 0.08 | 0.12 | 0.02 | 0.02 | 0.10 |
| EBITDA | 11.25 Million | - | 11.25 Million | 4.01 Million | 1.86 Million | 16.91 Million |
| Earnings Before Tax Margin | 0.19 | 0.12 | 0.19 | 0.04 | 0.04 | 0.18 |
IOS
688363
SICALLOG
002021
1732
PANXF